1. Home
  2. IRON vs ENPH Comparison

IRON vs ENPH Comparison

Compare IRON & ENPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$80.40

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Logo Enphase Energy Inc.

ENPH

Enphase Energy Inc.

HOLD

Current Price

$33.07

Market Cap

3.6B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
ENPH
Founded
2017
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
IRON
ENPH
Price
$80.40
$33.07
Analyst Decision
Strong Buy
Hold
Analyst Count
13
23
Target Price
$108.85
$41.89
AVG Volume (30 Days)
646.9K
5.7M
Earning Date
11-06-2025
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
233.44
EPS
N/A
1.44
Revenue
N/A
$1,512,377,000.00
Revenue This Year
N/A
$12.30
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$22.89
Revenue Growth
N/A
20.97
52 Week Low
$30.82
$25.78
52 Week High
$99.50
$76.90

Technical Indicators

Market Signals
Indicator
IRON
ENPH
Relative Strength Index (RSI) 35.05 57.45
Support Level $71.41 $31.56
Resistance Level $92.00 $34.12
Average True Range (ATR) 4.40 1.28
MACD -1.73 0.22
Stochastic Oscillator 31.96 68.32

Price Performance

Historical Comparison
IRON
ENPH

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About ENPH Enphase Energy Inc.

Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.

Share on Social Networks: